From: | Becker's Supply Chain Report <editorial@beckershealthcare.com> |
Subject: | 8 latest FDA approvals | What are US businesses' most pressing supply chain concerns? | NLRB issues labor complaint against CHS | Allergan pays $250M for licensing rights to AstraZeneca's experimental treatment |
Preheader: | |
Reply: | editorial@beckershealthcare.com |
|